Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Conrad Fischer

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
European Journal of Medicinal Chemistry|January 29, 2019
Plasma kallikrein cleaves and inactivates apelin-17: Palmitoyl- and PEG-extended apelin-17 analogs as metabolically stable blood pressure-lowering agentsConrad Fischer, Tess Lamer, Wang Wang, et al.
RSC Advances|November 6, 2024
Assessment of optimized FRET substrates as universal corona- and picornavirus main protease substrates for screening assaysConrad Fischer, Tayla J Van Oers, Marco J van Belkum, et al.
RSC Medicinal Chemistry|August 30, 2021
Metabolically stable apelin-analogues, incorporating cyclohexylalanine and homoarginine, as potent apelin receptor activatorsKleinberg X Fernandez, Conrad Fischer, Jennie Vu, et al.
Journal of Medicinal Chemistry|July 8, 2017
Synthetic Modification within the "RPRL" Region of Apelin Peptides: Impact on Cardiovascular Activity and Stability to Neprilysin and Plasma DegradationShaun M K McKinnie, Wang Wang, Conrad Fischer, et al.
Journal of Medicinal Chemistry|October 1, 2020
Optimizing PEG-Extended Apelin Analogues as Cardioprotective Drug Leads: Importance of the KFRR Motif and Aromatic Head Group for Improved Physiological ActivityConrad Fischer, Tess Lamer, Kleinberg Fernandez, et al.
RSC Medicinal Chemistry|August 18, 2025
Structural insights into the nirmatrelvir-resistant SARS-CoV-2 M<sup>pro</sup> L50F/E166A/L167F triple mutant-inhibitor-complex reveal strategies for next generation coronaviral inhibitor designConrad Fischer, Jimmy Lu, Marco J van Belkum, et al.
Frontiers in Chemistry|March 14, 2022
Crystallization of Feline Coronavirus M<sup>pro</sup> With GC376 Reveals Mechanism of InhibitionJimmy Lu, Sizhu Amelia Chen, Muhammad Bashir Khan, et al.
JACS Au|August 30, 2024
A Structural Comparison of Oral SARS-CoV-2 Drug Candidate Ibuzatrelvir Complexed with the Main Protease (M<sup>pro</sup>) of SARS-CoV-2 and MERS-CoVPu Chen, Tayla J Van Oers, Elena Arutyunova, et al.
Hepatology (Baltimore, Md.)|August 31, 2006
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis BKarsten Wursthorn, Marc Lutgehetmann, Maura Dandri, et al.
RSC Medicinal Chemistry|December 22, 2025
Screening apelin analogues and a small molecule agonist as effective cardiovascular therapeutics against reperfusion injuryAnjalee Wijewardane, Kleinberg X Fernandez, Anran Zhang, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
European Journal of Medicinal Chemistry|January 29, 2019
Plasma kallikrein cleaves and inactivates apelin-17: Palmitoyl- and PEG-extended apelin-17 analogs as metabolically stable blood pressure-lowering agentsConrad Fischer, Tess Lamer, Wang Wang, et al.
RSC Advances|November 6, 2024
Assessment of optimized FRET substrates as universal corona- and picornavirus main protease substrates for screening assaysConrad Fischer, Tayla J Van Oers, Marco J van Belkum, et al.
RSC Medicinal Chemistry|August 30, 2021
Metabolically stable apelin-analogues, incorporating cyclohexylalanine and homoarginine, as potent apelin receptor activatorsKleinberg X Fernandez, Conrad Fischer, Jennie Vu, et al.
Journal of Medicinal Chemistry|July 8, 2017
Synthetic Modification within the "RPRL" Region of Apelin Peptides: Impact on Cardiovascular Activity and Stability to Neprilysin and Plasma DegradationShaun M K McKinnie, Wang Wang, Conrad Fischer, et al.
Journal of Medicinal Chemistry|October 1, 2020
Optimizing PEG-Extended Apelin Analogues as Cardioprotective Drug Leads: Importance of the KFRR Motif and Aromatic Head Group for Improved Physiological ActivityConrad Fischer, Tess Lamer, Kleinberg Fernandez, et al.
RSC Medicinal Chemistry|August 18, 2025
Structural insights into the nirmatrelvir-resistant SARS-CoV-2 M<sup>pro</sup> L50F/E166A/L167F triple mutant-inhibitor-complex reveal strategies for next generation coronaviral inhibitor designConrad Fischer, Jimmy Lu, Marco J van Belkum, et al.
Frontiers in Chemistry|March 14, 2022
Crystallization of Feline Coronavirus M<sup>pro</sup> With GC376 Reveals Mechanism of InhibitionJimmy Lu, Sizhu Amelia Chen, Muhammad Bashir Khan, et al.
JACS Au|August 30, 2024
A Structural Comparison of Oral SARS-CoV-2 Drug Candidate Ibuzatrelvir Complexed with the Main Protease (M<sup>pro</sup>) of SARS-CoV-2 and MERS-CoVPu Chen, Tayla J Van Oers, Elena Arutyunova, et al.
Hepatology (Baltimore, Md.)|August 31, 2006
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis BKarsten Wursthorn, Marc Lutgehetmann, Maura Dandri, et al.
RSC Medicinal Chemistry|December 22, 2025
Screening apelin analogues and a small molecule agonist as effective cardiovascular therapeutics against reperfusion injuryAnjalee Wijewardane, Kleinberg X Fernandez, Anran Zhang, et al.
Pageof 4